Debra Farver

530 total citations
28 papers, 402 citations indexed

About

Debra Farver is a scholar working on Infectious Diseases, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Debra Farver has authored 28 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Psychiatry and Mental health and 4 papers in Epidemiology. Recurrent topics in Debra Farver's work include Electroconvulsive Therapy Studies (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Schizophrenia research and treatment (3 papers). Debra Farver is often cited by papers focused on Electroconvulsive Therapy Studies (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Schizophrenia research and treatment (3 papers). Debra Farver collaborates with scholars based in United States. Debra Farver's co-authors include Muhammad Owais Khan, Lorenz Hansen, Michael Lemon, Teresa Seefeldt, Surachat Ngorsuraches, M. Omar F. Khan and Thomas J. Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Pharmacology and Annals of Pharmacotherapy.

In The Last Decade

Debra Farver

26 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debra Farver United States	11	79	74	64	64	52	28	402
Antonio Portolés Spain	14	77 1.0×	33 0.4×	96 1.5×	60 0.9×	68 1.3×	82	600
Nicholas Zareifopoulos Greece	14	63 0.8×	88 1.2×	35 0.5×	106 1.7×	42 0.8×	23	468
Stefania Antoniazzi Italy	13	65 0.8×	64 0.9×	60 0.9×	83 1.3×	67 1.3×	33	481
May Adra United States	6	59 0.7×	103 1.4×	80 1.3×	43 0.7×	33 0.6×	12	283
Özgür Söğüt Türkiye	13	33 0.4×	45 0.6×	37 0.6×	60 0.9×	72 1.4×	94	515
Oliver L. Hung United States	11	59 0.7×	19 0.3×	55 0.9×	58 0.9×	25 0.5×	21	489
Chisato Shimanoe Japan	14	33 0.4×	65 0.9×	24 0.4×	50 0.8×	64 1.2×	62	467
Sarah McLeay Australia	11	24 0.3×	76 1.0×	80 1.3×	70 1.1×	27 0.5×	21	527
Jason B. Hack United States	13	79 1.0×	25 0.3×	67 1.0×	20 0.3×	41 0.8×	52	565
Erkki Palva Finland	14	37 0.5×	80 1.1×	74 1.2×	200 3.1×	18 0.3×	34	630

Countries citing papers authored by Debra Farver

Since Specialization

Citations

This map shows the geographic impact of Debra Farver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Farver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Farver more than expected).

Fields of papers citing papers by Debra Farver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Farver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Farver. The network helps show where Debra Farver may publish in the future.

Co-authorship network of co-authors of Debra Farver

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Farver. A scholar is included among the top collaborators of Debra Farver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Farver. Debra Farver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seefeldt, Teresa, et al.. (2017). Interprofessional education in pharmacology using high-fidelity simulation. Currents in Pharmacy Teaching and Learning. 9(6). 1055–1062. 23 indexed citations

Farver, Debra, et al.. (2017). Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures. The Journal of Clinical Pharmacology. 57(7). 811–817. 6 indexed citations

Lemon, Michael, et al.. (2012). Gabapentin Enacarbil for Treatment of Restless Legs Syndrome in Adults. Annals of Pharmacotherapy. 46(2). 229–239. 6 indexed citations

Farver, Debra, et al.. (2010). Dronedarone: A Safety Comparison to Amiodarone. Current Drug Safety. 5(3). 251–256. 6 indexed citations

Farver, Debra, et al.. (2010). A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy. Clinical Pharmacology Advances and Applications. 2. 95–95. 8 indexed citations

Farver, Debra, et al.. (2008). New advances in the treatment of Clostridium difficile infection (CDI). SHILAP Revista de lepidopterología. 8 indexed citations

Farver, Debra. (2008). Drug Information Handbook for Oncology: A Complete Guide to Combination Chemotherapy Regimens, 7th Edition. Annals of Pharmacotherapy. 42(10). 1522–1523.

Farver, Debra. (2008). New advances in the treatment of <em>Clostridium difficile</em> infection (CDI). Therapeutics and Clinical Risk Management. Volume 4(5). 949–964. 39 indexed citations

Farver, Debra. (2003). Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opinion on Drug Safety. 2(1). 21–35. 44 indexed citations

10.

Farver, Debra, et al.. (2003). Atypical antipsychotic induced mild hypothermia.. PubMed. 56(2). 67–70. 15 indexed citations

11.

Farver, Debra. (2003). Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opinion on Drug Safety. 2(1). 21–35. 1 indexed citations

12.

Farver, Debra. (2001). Weight gain and longterm complications with atypical antipsychotics.. PubMed. 54(1). 11–2. 2 indexed citations

13.

Khan, Muhammad Owais & Debra Farver. (2000). Recognition, assessment and management of neuroleptic malignant syndrome.. PubMed. 53(9). 395–400. 18 indexed citations

14.

Khan, M. Omar F. & Debra Farver. (2000). Rapid resolution of antipsychotic-induced tardive dyskinesia with olanzapine.. PubMed. 53(2). 65–7. 5 indexed citations

15.

Farver, Debra, et al.. (1999). Quinine-Induced Hepatotoxicity. Annals of Pharmacotherapy. 33(1). 32–34. 33 indexed citations

16.

Farver, Debra, et al.. (1998). Acute coalescent mastoiditis caused by antibiotic resistant organisms.. PubMed. 51(10). 379–83. 2 indexed citations

17.

Farver, Debra. (1997). Minocycline-Induced Lupus. Annals of Pharmacotherapy. 31(10). 1160–1163. 23 indexed citations

18.

Farver, Debra. (1997). Appropriate antibiotic use in long-term care facilities.. PubMed. 50(11). 411–2. 1 indexed citations

19.

Farver, Debra & Lorenz Hansen. (1994). Delayed Neutropenia with Ticlopidine. Annals of Pharmacotherapy. 28(12). 1344–1346. 12 indexed citations

20.

Farver, Debra. (1994). Cancer pain management.. PubMed. 47(11). 396–7. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact